ArticleCancer research2023

Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer.

Arnaldo Marín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.